Adverse Drug Reaction News Bulletins
ADR News Bulletin 2011 August (Volume 13 Number 2)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 August 2011
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
An update on the risk of intussusception with rotavirus vaccines
Counterfeit coloured contact lenses sold in Singapore
Association of venous and arterial thromboembolism with thalidomide and lenalidomide (Revlimid®)
Dronedarone (Multaq®) and severe hepatic injury
Risk of hypomagnesaemia associated with long-term use of proton pump inhibitors
Recent product safety-related articles published on HSA website
Updates on reclassified medicines in Singapore
Label updates on fluoroquinolones and QT prolongation
Topiramate (Topamax®) and risk of birth defects
Serious skin reactions associated with strontium ranelate (Protos®)
Click on the link below to download the issue in pdf: